[EN] SUBSTITUTED CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS<br/>[FR] CYANOPYRROLIDINES SUBSTITUÉES AYANT UNE ACTIVITÉ EN TANT QU'INHIBITEURS DE L'USP30
申请人:MISSION THERAPEUTICS LTD
公开号:WO2020212351A1
公开(公告)日:2020-10-22
The present invention relates to a class of substituted-cyanopyrrolidines with activity as inhibitors of the deubiquitylating enzyme USP30, having utility in a variety of therapeutic areas, including conditions involving mitochondrial dysfunction, cancer and fibrosis: (I).
本发明涉及一类取代氰基吡咯烷酮,具有作为去泛素化酶USP30抑制剂的活性,在包括涉及线粒体功能障碍、癌症和纤维化等多种治疗领域中具有用途:(I)。